All Research
    PAPER CERAMIMeta-analysis2026

    Prognostic performance of ceramide-based risk scores for cardiovascular events and mortality in patients with coronary artery disease and heart failure: a systematic review and dose-response meta-analysis

    2026 systematic review and dose-response meta-analysis: the CERT2 ceramide-phospholipid risk score showed a significant graded (linear) association with major adverse cardiovascular events (RR ~1.09 per one-unit increase).

    Evidence

    —

    Not Rated

    Sample

    —

    subjects

    Duration

    —

    study period

    Journal

    European Journal of Medical Research

    Jan 2026

    03

    Structured Methods

    Study Design
    Meta-analysis
    Sample Size
    Not reported
    Study Duration
    Not reported
    Methodology
    Not reported
    Limitations
    Not reported
    04

    Citations & References

    Cite this paper

    Unknown authors (2026). Prognostic performance of ceramide-based risk scores for cardiovascular events and mortality in patients with coronary artery disease and heart failure: a systematic review and dose-response meta-analysis. European Journal of Medical Research. https://doi.org/10.1186/s40001-026-04470-1

    DOI

    10.1186/s40001-026-04470-1

    Source

    Publisher

    Journal

    European Journal of Medical Research

    05

    Indexing

    Biomarkers

    ceramides
    PHS
    671
    / 1000
    T3
    Longevity Operator

    Sample member

    Longevity Operator

    The Peak Human Score · PHS v1

    One number for your longevity journey.

    FICO for credit. PHS for longevity. Eight biological domains collapsed into one provable score — intuitive at a glance, rigorous underneath.

    • Metabolic
    • Hormonal
    • Cardiovascular
    • Brain / Cognitive
    • Sleep
    • Musculoskeletal
    • Gut
    • Immunity / Inflammation